VS 41157
Alternative Names: VS-41157Latest Information Update: 31 Mar 2023
At a glance
- Originator VeroScience
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pancreatic cancer
Most Recent Events
- 22 Mar 2023 Preclinical trials in Pancreatic cancer in USA, prior to March 2023 (VeroScience pipeline, March 2023)